Atul Pande

Atul Pande

Directeur/Membre du Conseil chez IMMUNOVANT, INC.

Fortune : 5 M $ au 30/06/2026

71 ans
Health Technology
Commercial Services
Consumer Services

Profil

Atul C.
Pande
currently works at Verity BioConsulting LLC, as President & Chief Executive Officer from 2014, Roivant Sciences, Inc., as Director, Immunovant Sciences Ltd., as Director from 2019, Immunovant, Inc., as Independent Director from 2019, and Pangea Botanica Ltd., as Non-Executive Director from 2022.
Dr. Pande also formerly worked at Nxera Pharma UK Ltd., as Director, Parke-Davis Pharmaceutical Research, Inc., as Senior Director, Sio Gene Therapies, Inc., as Lead Independent Director from 2018 to 2023, Immunovant, Inc., as Director, Karuna Therapeutics, Inc., as Independent Director from 2019 to 2024, Autifony Therapeutics Ltd., as Non-Executive Director from 2013 to 2023, Perception Neuroscience, Inc., as Non-Executive Director from 2019 to 2023, Eli Lilly & Co., as Vice President, Pfizer Inc., as Vice President-Neurosciences, CeNeRx BioPharma, Inc., as Chief Medical Officer, Tal Medical, Inc., as Chief Medical Officer & Executive Vice President from 2014 to 2017, GSK Plc, as Senior Vice President from 2007 to 2014, Lilly Research Laboratories, as Principal, the University of Michigan Medical School, as Assistant Professor, and PureTech Health Plc, as Chief Medical Officer from 2017 to 2018.
Dr. Pande received his undergraduate degree and doctorate degree from the University of Lucknow.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2026 122 851 ( 0,06 % ) 5 M $ 30/06/2026

Postes actifs de Atul Pande

SociétésPosteDébut
IMMUNOVANT, INC. Directeur/Membre du Conseil 18/12/2019
Directeur/Membre du Conseil 01/10/2019
Directeur/Membre du Conseil -
Verity BioConsulting LLC
Directeur Général 01/01/2014
Directeur/Membre du Conseil 01/12/2022

Anciens postes connus de Atul Pande

SociétésPosteFin
KARA THER Directeur/Membre du Conseil 18/03/2024
Directeur/Membre du Conseil 01/12/2023
Directeur/Membre du Conseil 01/12/2023
SIO GENE THERAPIES INC. Directeur/Membre du Conseil 05/04/2023
░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Atul Pande

Formation de Atul Pande

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

61

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Parke-Davis Pharmaceutical Research, Inc.

Consumer Services

Health Technology

Health Technology

Consumer Services

Verity BioConsulting LLC

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Atul Pande
🔇